Literature DB >> 9585388

Postmenopausal virilization in a woman with gonadotropin dependent ovarian hyperthecosis.

C Manieri1, C Di Bisceglie, R Fornengo, T Grosso, E Zumpano, F Calvo, E Berardengo, M Volante, M Papotti.   

Abstract

We report a case of a 66-yr-old woman with progressive hair balding, hirsutism and virilization. Gonadotropins and estradiol levels were in the postmenopausal range; total testosterone (TT), free testosterone (FT) and 17-hydroxyprogesterone (17-OHP) were elevated with dehydroepiandrosterone sulphate, androstendione and cortisol serum levels in the normal range, as 24-hr free urinary cortisol. TT, FT and 17-OHP were normalized, and FSH and LH fell to premenopausal levels on 18th day after a single i.m. injection of the GnRH analogue (GnRHa), triptorelin. Then, a diagnosis of hyperandrogenism of ovarian origin was made and bilateral ovariectomy was performed. Histological study of gonadal tissue revealed diffuse stromal hyperplasia of both ovaries with occasional nests of luteinized cells. With immunoperoxidase techniques these cells stained positively for testosterone and progesterone. One month after surgery, androgen levels were normalized together with regression of most of the clinical signs of virilization. In conclusion, our patient showed a severe virilization developed after menopause; hormonal investigations suggested a gonadotropin dependent ovarian hyperandrogenism, confirmed by histological examination; the presence of luteinized cells in the ovarian stroma was responsible for hyperandrogenism, as confirmed by the immunoperoxidase technique.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9585388     DOI: 10.1007/BF03350327

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  13 in total

1.  Ovarian hyperthecosis, diabetes and hirsuties in post-menopausal women.

Authors:  J H Barth; M Jenkins; P E Belchetz
Journal:  Clin Endocrinol (Oxf)       Date:  1997-02       Impact factor: 3.478

2.  Effect of androgen on adrenal steroidogenesis in normal women.

Authors:  M Vermesh; P D Silva; G F Rosen; A G Vijod; R A Lobo
Journal:  J Clin Endocrinol Metab       Date:  1988-01       Impact factor: 5.958

3.  Polycystic ovary syndrome, hyperthecosis and the menopause.

Authors:  R S Rittmaster
Journal:  Clin Endocrinol (Oxf)       Date:  1997-02       Impact factor: 3.478

4.  Treatment of severe androgen excess due to ovarian hyperthecosis with a long-acting gonadotropin-releasing hormone agonist.

Authors:  K A Steingold; H L Judd; R K Nieberg; J K Lu; R J Chang
Journal:  Am J Obstet Gynecol       Date:  1986-06       Impact factor: 8.661

Review 5.  The climacteric ovary as a functional gonadotropin-driven androgen-producing gland.

Authors:  E Y Adashi
Journal:  Fertil Steril       Date:  1994-07       Impact factor: 7.329

6.  Short term administration of gonadotropin-releasing hormone analog to a patient with a testosterone-secreting ovarian tumor.

Authors:  L Kennedy; A I Traub; A B Atkinson; B Sheridan
Journal:  J Clin Endocrinol Metab       Date:  1987-06       Impact factor: 5.958

7.  Overdiagnosis of 21-hydroxylase late onset congenital adrenal hyperplasia: correlation of corticotropin test and human leukocyte antigen typing.

Authors:  I Avivi; S Pollack; O Gideoni; S Linn; Z Blumenfeld
Journal:  Fertil Steril       Date:  1996-10       Impact factor: 7.329

8.  A gonadotrophin dependent stromal luteoma: a rare cause of post-menopausal virilization.

Authors:  A Chico; J L García; X Matías-Guiu; S M Webb; J Rodríguez; J Prat; J Calaf
Journal:  Clin Endocrinol (Oxf)       Date:  1995-11       Impact factor: 3.478

9.  Direct in-vivo detection of atypical hormonal expression of a Sertoli-Leydig cell tumour following stimulation with human chorionic gonadotrophin.

Authors:  I Cohen; M Shapira; S Cuperman; S Goldberger; A Siegal; M Altaras; Y Beyth
Journal:  Clin Endocrinol (Oxf)       Date:  1993-10       Impact factor: 3.478

10.  Androgen suppressive effect of GnRH agonist in ovarian hyperthecosis and virilizing tumours.

Authors:  M M Pascale; M Pugeat; M Roberts; H Rousset; H Déchaud; N Dutrieux-Berger; J Tourniaire
Journal:  Clin Endocrinol (Oxf)       Date:  1994-11       Impact factor: 3.478

View more
  3 in total

Review 1.  Menopause in nonhuman primates?

Authors:  Margaret L Walker; James G Herndon
Journal:  Biol Reprod       Date:  2008-05-21       Impact factor: 4.285

2.  Acute goserelin administration inhibits gonadotropin and androgen secretion in post-menopausal women with ovarian hyperandrogenism.

Authors:  C Di Bisceglie; L Brocato; M Tagliabue; A Bertagna; L Gianotti; E Ghigo; C Manieri
Journal:  J Endocrinol Invest       Date:  2003-03       Impact factor: 4.256

3.  Hyperandrogenism in menopause: a case report and literature review.

Authors:  Andrey V Dolinko; Elizabeth S Ginsburg
Journal:  Fertil Res Pract       Date:  2015-05-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.